Hypertension

≥ 140/90 mm Hg Existing cardiovascular disease (coronary heart disease, stroke, or heart failure) and average BP ≥ 130 mm Hg systolic or ≥ 80 mm Hg diastolic Diabetes, chronic kidney disease or 10-year PREVENT cardiovascular risk ≥ 7.5% and average BP ≥ 130 mm Hg systolic or ≥ 80 mm Hg diastolic Persistent average BP ≥ 130 mm Hg systolic or ≥ 80 mm Hg diastolic after 3 to 6 months of lifestyle intervention An important part of management is continued reassessment. If patients are not at goal BP, clinicians should strive to optimize adherence to the current regimen before switching or adding medications. Treatment of hypertension during pregnancy requires careful medication selection because some antihypertensive medications can harm the fetus. Medication selection is based on several factors, including comorbidities, contraindications, and tolerability. For most patients, when selecting an agent for monotherapy, initial treatment may be with any of the following medication classes: Angiotensin-converting enzyme (ACE) inhibitor Angiotensin II receptor blocker (ARB) Dihydropyridine calcium channel blocker 13/20 Thiazide diuretic (preferably a thiazide-like diuretic such as chlorthalidone or indapamide) Adults with stage 1 hypertension (systolic BP 130 to 139/diastolic BP 80 to 89 mm Hg) may be treated initially with
